caffeic acid phenethyl ester has been researched along with g(m3) ganglioside in 1 studies
Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (g(m3) ganglioside) | Trials (g(m3) ganglioside) | Recent Studies (post-2010) (g(m3) ganglioside) |
---|---|---|---|---|---|
840 | 1 | 469 | 1,010 | 17 | 222 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YC; Choi, HJ; Chung, TW; Ha, KT; Jin, UH; Kim, CH; Kwak, CH; Lee, YC; Song, KH | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and g(m3) ganglioside
Article | Year |
---|---|
Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells.
Topics: Antioxidants; Caffeic Acids; Cell Differentiation; Cell Proliferation; G(M3) Ganglioside; Humans; K562 Cells; Megakaryocytes; Phenylethyl Alcohol | 2014 |